171 related articles for article (PubMed ID: 31142721)
1. Risk assessment and survival of patients with pulmonary hypertension: Multicenter experience in Turkey.
Yaylalı YT; Başarıcı I; Kılıçkıran Avcı B; Meriç M; Sinan ÜY; Şenol H; Küçükoğlu MS; Öngen Z
Anatol J Cardiol; 2019 Jun; 21(6):322-330. PubMed ID: 31142721
[TBL] [Abstract][Full Text] [Related]
2. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
3. [The value of brain natriuretic peptide in connective tissue diseases associated with pulmonary arterial hypertension].
Tian Z; Guo XX; Li MT; Wang Q; Liu YT; Zhao JL; Fang Q; Zeng XF
Zhonghua Nei Ke Za Zhi; 2011 Feb; 50(2):102-6. PubMed ID: 21418827
[TBL] [Abstract][Full Text] [Related]
4. Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease.
Li X; Sun X; Huang Y; Wang Y; Yang X; Wang J; Zhang N; Gu L; Zhang M; Wang Q
Clin Rheumatol; 2019 Dec; 38(12):3619-3626. PubMed ID: 31385084
[TBL] [Abstract][Full Text] [Related]
5. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
[TBL] [Abstract][Full Text] [Related]
6. Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcome.
Ploegstra MJ; Roofthooft MT; Douwes JM; Bartelds B; Elzenga NJ; van de Weerd D; Hillege HL; Berger RM
Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552488
[TBL] [Abstract][Full Text] [Related]
7. Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study.
Ngian GS; Stevens W; Prior D; Gabbay E; Roddy J; Tran A; Minson R; Hill C; Chow K; Sahhar J; Proudman S; Nikpour M
Arthritis Res Ther; 2012 Oct; 14(5):R213. PubMed ID: 23039366
[TBL] [Abstract][Full Text] [Related]
8. Right atrial function for the prediction of prognosis in connective tissue disease-associated pulmonary arterial hypertension: a study with two-dimensional speckle tracking.
Bai Y; Yang J; Liu J; Ning H; Zhang R
Int J Cardiovasc Imaging; 2019 Sep; 35(9):1637-1649. PubMed ID: 31037473
[TBL] [Abstract][Full Text] [Related]
9. Mortality in pulmonary arterial hypertension due to congenital heart disease: Serial changes improve prognostication.
Schuijt MTU; Blok IM; Zwinderman AH; van Riel ACMJ; Schuuring MJ; de Winter RJ; Duijnhouwer AL; van Dijk APJ; Mulder BJM; Bouma BJ
Int J Cardiol; 2017 Sep; 243():449-453. PubMed ID: 28606655
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Instrumental Characteristics of Newly Diagnosed Patients with Various Forms of Pulmonary Hypertension according to the Russian National Registry.
Chazova IY; Martynyuk TV; Valieva ZS; Gratsianskaya SY; Aleevskaya AM; Zorin AV; Nakonechnikov SN
Biomed Res Int; 2020; 2020():6836973. PubMed ID: 32626754
[TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T
Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710
[TBL] [Abstract][Full Text] [Related]
12. Risk Assessment Tool Implementation in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension.
Yaylalı YT; Yağmur B; Sinan ÜY; Meriç M; Başarıcı İ; Kılıçkıran Avcı B; Şenol H; Nalbantgil S; Küçükoğlu S; Öngen Z
Anatol J Cardiol; 2023 Aug; 27(8):479-485. PubMed ID: 37288853
[TBL] [Abstract][Full Text] [Related]
13. New predictors of mortality in adults with congenital heart disease and pulmonary hypertension: Midterm outcome of a prospective study.
Schuuring MJ; van Riel AC; Vis JC; Duffels MG; van Dijk AP; de Bruin-Bon RH; Zwinderman AH; Mulder BJ; Bouma BJ
Int J Cardiol; 2015 Feb; 181():270-6. PubMed ID: 25535690
[TBL] [Abstract][Full Text] [Related]
14. Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients.
Delcroix M; Staehler G; Gall H; Grünig E; Held M; Halank M; Klose H; Vonk-Noordegraaf A; Rosenkranz S; Pepke-Zaba J; Opitz CF; Gibbs JSR; Lange TJ; Tsangaris I; Huscher D; Pittrow D; Olsson KM; Hoeper MM
Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30337446
[TBL] [Abstract][Full Text] [Related]
15. Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis.
Rosenkranz S; Pausch C; Coghlan JG; Huscher D; Pittrow D; Grünig E; Staehler G; Vizza CD; Gall H; Distler O; Delcroix M; Ghofrani HA; Ewert R; Kabitz HJ; Skowasch D; Behr J; Milger K; Halank M; Wilkens H; Seyfarth HJ; Held M; Scelsi L; Neurohr C; Vonk-Noordegraaf A; Ulrich S; Klose H; Claussen M; Eisenmann S; Schmidt KH; Remppis BA; Skride A; Jureviciene E; Gumbiene L; Miliauskas S; Löffler-Ragg J; Lange TJ; Olsson KM; Hoeper MM; Opitz C
J Heart Lung Transplant; 2023 Jan; 42(1):102-114. PubMed ID: 36333206
[TBL] [Abstract][Full Text] [Related]
16. [Value of cardiopulmonary exercise testing in comparing cardio-pulmonary function among patients with three kinds of pulmonary artery hypertension].
Zhao Q; Liu Z; Ma X; Zhao Z; Luo Q; Gu Q; Xiong C; Zhang H; Wang Y
Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(44):3598-601. PubMed ID: 26813372
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.
Boucly A; Weatherald J; Savale L; Jaïs X; Cottin V; Prevot G; Picard F; de Groote P; Jevnikar M; Bergot E; Chaouat A; Chabanne C; Bourdin A; Parent F; Montani D; Simonneau G; Humbert M; Sitbon O
Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28775050
[TBL] [Abstract][Full Text] [Related]
18. [Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry].
Chazova IE; Valieva ZS; Nakonechnikov SN; Taran IN; Martynyuk TV
Ter Arkh; 2019 Sep; 91(9):77-87. PubMed ID: 32598818
[TBL] [Abstract][Full Text] [Related]
19. A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines.
Dardi F; Manes A; Guarino D; Zuffa E; De Lorenzis A; Magnani I; Rotunno M; Ballerini A; Lo Russo GV; Nardi E; Galiè N; Palazzini M
Open Heart; 2021 Oct; 8(2):. PubMed ID: 34667092
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
